Advancing new drug therapies for unmet medical needs

Developing novel drug therapies for unmet medical needs 2018-11-14T18:17:53+00:00

The Dimerix Limited Clinical Trials – ACTION for Diabetic Kidney Disease and ACTION for Focal Segmental Glomerulosclerosis – Are Now Open!

Click Here For More Information

Dimerix Limited is a clinical stage biotechnology company that is listed on the Australian Stock Exchange (ASX:DXB)

Our vision is to positively improve human health by creating safe and effective new treatments for patients with unmet medical needs

Recent news and media

2018 CEO’s AGM presentation – investor call recording

Dr Nina Webster, CEO of Dimerix, presented to shareholders at the 2018 AGM where she provided a review of key highlights [...]

ASX: AGM Presentation and CEO Address

For the slides presented at the AGM on the 30th October 2018, click here.

Click here to view analyst coverage
Click here to view our corporate fact sheet
Click here to view our corporate presentation